supplement-probiotic-wbf-010-inulin-clostridium-bifidobacterium-generic

Outcomes

01
biomarker-c-reactive-protein-serum-milligrams-per-liter-measured
1 evidence row
- perraudeau_2020_rct_improvements-to-postprandial-glucose-control-in-subjects-with-type-2-diabetes-a-multicenter-double-blind-randomized-placebo-controlled-trial-of-a-novel-probiotic-formulation
02
biomarker-interleukin-10-serum-picograms-per-milliliter-measured
1 evidence row
- perraudeau_2020_rct_improvements-to-postprandial-glucose-control-in-subjects-with-type-2-diabetes-a-multicenter-double-blind-randomized-placebo-controlled-trial-of-a-novel-probiotic-formulation
03
biomarker-interleukin-6-serum-picograms-per-milliliter-measured
1 evidence row
- perraudeau_2020_rct_improvements-to-postprandial-glucose-control-in-subjects-with-type-2-diabetes-a-multicenter-double-blind-randomized-placebo-controlled-trial-of-a-novel-probiotic-formulation
04
biomarker-stool-short-chain-fatty-acid-acetate-millimoles-per-gram-measured
1 evidence row
- perraudeau_2020_rct_improvements-to-postprandial-glucose-control-in-subjects-with-type-2-diabetes-a-multicenter-double-blind-randomized-placebo-controlled-trial-of-a-novel-probiotic-formulation
05
biomarker-stool-short-chain-fatty-acid-butyrate-millimoles-per-gram-measured
1 evidence row
- perraudeau_2020_rct_improvements-to-postprandial-glucose-control-in-subjects-with-type-2-diabetes-a-multicenter-double-blind-randomized-placebo-controlled-trial-of-a-novel-probiotic-formulation
06
biomarker-stool-short-chain-fatty-acid-propionate-millimoles-per-gram-measured
1 evidence row
- perraudeau_2020_rct_improvements-to-postprandial-glucose-control-in-subjects-with-type-2-diabetes-a-multicenter-double-blind-randomized-placebo-controlled-trial-of-a-novel-probiotic-formulation
07
biomarker-transforming-growth-factor-beta-serum-picograms-per-milliliter-measured
1 evidence row
- perraudeau_2020_rct_improvements-to-postprandial-glucose-control-in-subjects-with-type-2-diabetes-a-multicenter-double-blind-randomized-placebo-controlled-trial-of-a-novel-probiotic-formulation
08
biomarker-tumor-necrosis-factor-alpha-serum-picograms-per-milliliter-measured
1 evidence row
- perraudeau_2020_rct_improvements-to-postprandial-glucose-control-in-subjects-with-type-2-diabetes-a-multicenter-double-blind-randomized-placebo-controlled-trial-of-a-novel-probiotic-formulation
09
body-composition-weight-kilograms-measured
1 evidence row
- perraudeau_2020_rct_improvements-to-postprandial-glucose-control-in-subjects-with-type-2-diabetes-a-multicenter-double-blind-randomized-placebo-controlled-trial-of-a-novel-probiotic-formulation
10
glucose-fasting-serum-milligrams-per-deciliter-measured
1 evidence row
- perraudeau_2020_rct_improvements-to-postprandial-glucose-control-in-subjects-with-type-2-diabetes-a-multicenter-double-blind-randomized-placebo-controlled-trial-of-a-novel-probiotic-formulation
11
glucose-glycated-hemoglobin-a1c-serum-percent-measured
1 evidence row
- perraudeau_2020_rct_improvements-to-postprandial-glucose-control-in-subjects-with-type-2-diabetes-a-multicenter-double-blind-randomized-placebo-controlled-trial-of-a-novel-probiotic-formulation
12
glucose-incremental-area-under-the-curve-0-to-180-minutes-meal-tolerance-test-measured
1 evidence row
- perraudeau_2020_rct_improvements-to-postprandial-glucose-control-in-subjects-with-type-2-diabetes-a-multicenter-double-blind-randomized-placebo-controlled-trial-of-a-novel-probiotic-formulation
13
glucose-insulin-resistance-homa-ir-score-measured
1 evidence row
- perraudeau_2020_rct_improvements-to-postprandial-glucose-control-in-subjects-with-type-2-diabetes-a-multicenter-double-blind-randomized-placebo-controlled-trial-of-a-novel-probiotic-formulation
14
glucose-total-area-under-the-curve-0-to-180-minutes-meal-tolerance-test-measured
1 evidence row
- perraudeau_2020_rct_improvements-to-postprandial-glucose-control-in-subjects-with-type-2-diabetes-a-multicenter-double-blind-randomized-placebo-controlled-trial-of-a-novel-probiotic-formulation

supplement-probiotic-wbf-010-inulin-clostridium-bifidobacterium-generic

Outcomes

biomarker-c-reactive-protein-serum-milligrams-per-liter-measured

biomarker-interleukin-10-serum-picograms-per-milliliter-measured

biomarker-interleukin-6-serum-picograms-per-milliliter-measured

biomarker-stool-short-chain-fatty-acid-acetate-millimoles-per-gram-measured

biomarker-stool-short-chain-fatty-acid-butyrate-millimoles-per-gram-measured

biomarker-stool-short-chain-fatty-acid-propionate-millimoles-per-gram-measured

biomarker-transforming-growth-factor-beta-serum-picograms-per-milliliter-measured

biomarker-tumor-necrosis-factor-alpha-serum-picograms-per-milliliter-measured

body-composition-weight-kilograms-measured

glucose-fasting-serum-milligrams-per-deciliter-measured

glucose-glycated-hemoglobin-a1c-serum-percent-measured

glucose-incremental-area-under-the-curve-0-to-180-minutes-meal-tolerance-test-measured

glucose-insulin-resistance-homa-ir-score-measured

glucose-total-area-under-the-curve-0-to-180-minutes-meal-tolerance-test-measured